PPMD Invests $400,000 in MyoGene Bio to Advance Gene Editing Research The Parent Project Muscular Dystrophy has secured $400,000 in funding for MyoGene Bio, significantly advancing research on Duchenne muscular dystrophy using gene editing technology.

PPMD Invests $400,000 in MyoGene Bio to Advance Gene Editing Research #USA #San_Diego #Duchenne_MD #MyoGene_Bio #PPMD_Venture